US Stock MarketDetailed Quotes
REPL Replimune
- 12.560
- +0.450+3.72%
Close Jan 2 16:00 ET
- 12.560
- 0.0000.00%
Post 16:01 ET
946.28MMarket Cap-4.13P/E (TTM)
13.560High12.170Low1.16MVolume12.380Open12.110Pre Close14.79MTurnover2.29%Turnover RatioLossP/E (Static)75.34MShares17.00052wk High2.53P/B634.49MFloat Cap4.92052wk Low--Dividend TTM50.52MShs Float54.850Historical High--Div YieldTTM11.48%Amplitude4.920Historical Low12.784Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Replimune Stock Forum
The market overall advanced Friday. Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +0.35%, the $Dow Jones Industrial Average (.DJI.US)$ climbed 0.97%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.16%.
MACRO
In macroeconomics, S&P Global released its composite and service PMI. Composite came in at a two-year high, 55.3...
$Super Micro Computer (SMCI.US)$ climbed 15%, after earlier this week, the firm said it submitted a plan to release its six-month delayed 10k with a new auditor, BDO USA, and filed for a time extension to file it...
Replimune Receives Breakthrough Therapy Designation for Rp1 and Submits Rp1 Biologics License Application to the FDA Under the Accelerated Approval Pathway
No comment yet